Neuroanesthesia

🧠 Neuroanesthesia: The Brain's Guardian Protocol

Neuroanesthesia demands you master a paradox: your drugs must render the brain unconscious while simultaneously protecting its fragile perfusion, metabolism, and structure during surgery. You'll learn how cerebral blood flow responds to anesthetic agents, why positioning can catastrophically alter intracranial pressure, and how to monitor a patient whose neurological exam you've deliberately abolished. This lesson builds your framework for managing the body's most unforgiving organ-where small missteps cascade into irreversible damage, and where vigilance from induction through emergence separates excellent outcomes from disaster.

Neurosurgeon performing awake craniotomy with patient conscious

Neuroanesthesia represents the pinnacle of perioperative medicine, where anesthetic decisions directly influence cerebral perfusion pressure, intracranial pressure dynamics, and neurological outcomes. Every drug choice, every ventilation parameter, and every hemodynamic adjustment reverberates through the brain's delicate physiology.

📌 Remember: BRAIN for neuroanesthesia priorities - Blood pressure control, Respiratory management, Anesthetic depth, ICP monitoring, Neurological assessment

The neuroanesthetic approach fundamentally differs from general anesthesia through its focus on cerebral protection, rapid emergence, and immediate neurological assessment. Understanding these principles unlocks the logic behind every neuroanesthetic decision.

⭐ Clinical Pearl: Neuroanesthesia maintains CPP >70 mmHg while keeping ICP <20 mmHg - the golden ratio for cerebral perfusion

Parameter	Target Range	Critical Threshold	Monitoring Method	Clinical Significance
CPP	70-100 mmHg	<60 mmHg	Arterial line + ICP	Brain perfusion adequacy
ICP	<15 mmHg	>20 mmHg	Direct monitoring	Herniation risk
PaCO2	35-40 mmHg	<30 or >45	ABG analysis	CBF regulation
MAP	80-100 mmHg	<65 mmHg	Arterial monitoring	Autoregulation zone
Temperature	36-37°C	>38°C	Core monitoring	Neuroprotection

🧠 Neuroanesthesia: The Brain's Guardian Protocol

Awake Craniotomy

Cerebral Physiology and Pathophysiology

⚡ Cerebral Hemodynamics: The Brain's Circulation Command Center

Cerebral Blood Flow (CBF) averages 50 mL/100g/min in gray matter and 20 mL/100g/min in white matter, totaling approximately 750 mL/min or 15% of cardiac output. This massive perfusion requirement reflects the brain's 20% share of total body oxygen consumption despite representing only 2% of body weight.

📌 Remember: FLOW determines CBF - Factor responsiveness (CO2, O2), Location autoregulation, Oxygen consumption coupling, Wave pressure relationships

Autoregulation Mechanisms:

Myogenic Response: Vascular smooth muscle responds to transmural pressure changes within 15-30 seconds
- Pressure ↑ → vasoconstriction → CBF maintained
- Pressure ↓ → vasodilation → CBF preserved
- Critical threshold: Fails below MAP 50 mmHg or above 150 mmHg
Metabolic Coupling: CMRO2 directly correlates with CBF through adenosine and lactate signaling
- Normal CMRO2: 3.5 mL O2/100g/min
- Ischemic threshold: CBF <18-20 mL/100g/min
Chemical Regulation: PaCO2 provides most potent CBF control
- CO2 reactivity: 2-4% CBF change per mmHg PaCO2
- Hyperventilation: PaCO2 25-30 mmHg reduces CBF by 30-40%

⭐ Clinical Pearl: Hyperventilation provides rapid ICP reduction but risks cerebral ischemia - limit to PaCO2 30-35 mmHg and duration <30 minutes

💡 Master This: Monroe-Kellie Doctrine governs intracranial dynamics - brain (80%) + blood (10%) + CSF (10%) = constant volume. Any increase in one component demands compensatory reduction in others.

Understanding cerebral hemodynamics transforms your approach to neuroanesthetic management, providing the physiological foundation for every intervention from positioning to pharmacological manipulation.

⚡ Cerebral Hemodynamics: The Brain's Circulation Command Center

Anesthetics and Cerebral Blood Flow

Intracranial Pressure Management

🎯 Anesthetic Agents: The Neurochemical Arsenal

Intravenous Anesthetic Effects on CBF and CMRO2:

📌 Remember: GABA agents for neuroprotection - Good CBF reduction, Anticonvulsant properties, Brain protection, Autoregulation preserved

Propofol: The neuroanesthetic gold standard
- CBF reduction: 30-50% dose-dependent
- CMRO2 reduction: 35-60% with burst suppression at >4 mg/kg/hr
- ICP reduction: 25-40% through vasoconstriction
- Neuroprotection: Antioxidant properties + GABA enhancement
- Emergence: Context-sensitive half-time increases from 10 minutes (2 hours) to 50 minutes (8+ hours)
Etomidate: Hemodynamic stability champion
- CBF reduction: 35-45% with autoregulation preserved
- Cardiovascular stability: Minimal MAP changes even in shock states
- Limitation: Adrenal suppression lasting 6-24 hours
- Indication: Hemodynamically unstable patients requiring neuroprotection

EEG waveforms showing burst suppression pattern during deep anesthesia

Volatile Anesthetic Considerations:

Agent	CBF Effect	CMRO2 Effect	ICP Impact	MAC-Awake	Neuroprotection
Sevoflurane	↑20-40%	↓30-50%	↑Mild	0.3-0.5	Preconditioning
Isoflurane	↑50-80%	↓45-65%	↑Moderate	0.25-0.4	Controversial
Desflurane	↑60-100%	↓40-60%	↑Significant	0.3-0.5	Limited data

Neuromuscular Blocking Considerations:

Rocuronium: Onset 60-90 seconds, duration 30-60 minutes, sugammadex reversible
- Intubating dose: 0.6-1.2 mg/kg for rapid sequence
- Maintenance: 0.15 mg/kg every 20-30 minutes
Vecuronium: Onset 90-120 seconds, duration 25-45 minutes, hepatic elimination
- Preferred in renal dysfunction due to hepatic metabolism
Avoid succinylcholine: ICP increase of 5-15 mmHg lasting 5-10 minutes

💡 Master This: Total intravenous anesthesia (TIVA) with propofol + remifentanil provides optimal ICP control, rapid emergence, and immediate neurological assessment - the neuroanesthetic technique of choice.

Connect these pharmacological principles through positioning strategies to understand how anesthetic choices integrate with surgical requirements and patient safety.

🎯 Anesthetic Agents: The Neurochemical Arsenal

Anesthesia for Supratentorial Craniotomy

Anesthesia for Traumatic Brain Injury

🔄 Positioning Protocols: The Spatial Strategy Matrix

Position-Specific Physiological Impacts:

📌 Remember: HEADS for positioning priorities - Hemodynamics, Eye protection, Airway security, Drainage optimization, Safety monitoring

Supine Position: Foundation for supratentorial procedures
- Head elevation: 15-30 degrees improves venous drainage by 20-30%
- Neck rotation: Limit to <45 degrees to prevent jugular compression
- CPP maintenance: Minimal hydrostatic gradient preserves cerebral perfusion
- Complications: Macroglossia risk with prolonged procedures >6 hours
Lateral Position: Temporal and parietal access optimization
- Dependent ear protection: Gel padding prevents pressure necrosis
- Axillary roll: Prevents brachial plexus compression and vascular compromise
- Venous drainage: Operative side up enhances gravitational drainage
- Monitoring: Dependent eye requires frequent assessment

Anatomical diagram showing venous drainage pathways in different head positions

High-Risk Positioning Considerations:

Position	Primary Risk	Monitoring Priority	Prevention Strategy	Complication Rate
Prone	VAE	Precordial Doppler	CVP monitoring	2-5%
Sitting	VAE + Hypotension	TEE + Arterial line	Volume loading	10-25%
Lateral	Pressure injuries	Pulse checks	Padding protocols	1-3%
Supine	Macroglossia	Tongue assessment	Bite block	<1%

Venous Air Embolism (VAE): Incidence 2-5% due to negative venous pressure
Cardiovascular effects: Decreased venous return and cardiac output ↓15-25%
Respiratory changes: FRC reduction and V/Q mismatch
Monitoring essentials: Precordial Doppler, ETCO2, CVP access

⭐ Clinical Pearl: Sitting position carries VAE risk up to 25% but provides optimal surgical access for posterior fossa - requires TEE monitoring and immediate VAE management protocols

Venous Air Embolism Management Protocol:

Recognition: Mill-wheel murmur, ETCO2 ↓, hypotension, arrhythmias
Immediate actions: 100% O2, flood surgical field, left lateral Trendelenburg
Advanced management: Central line aspiration, vasopressor support
Prevention: PEEP 5-10 cmH2O, adequate hydration, CVP >5 mmHg

Diagram showing venous air embolism pathophysiology and treatment

💡 Master This: Position-related complications account for 15-20% of neuroanesthetic morbidity - meticulous pressure point padding, physiological monitoring, and VAE vigilance prevent most adverse outcomes.

These positioning principles connect directly with intraoperative monitoring strategies, where continuous assessment ensures patient safety throughout complex neurosurgical procedures.

🔄 Positioning Protocols: The Spatial Strategy Matrix

Anesthesia for Infratentorial Craniotomy

Anesthesia for Spine Surgery

📊 Monitoring Mastery: The Neurological Surveillance Network

Multimodal neuromonitoring setup showing ICP, EEG, and evoked potentials

Essential Neuroanesthetic Monitoring Parameters:

📌 Remember: MONITOR for comprehensive surveillance - MAP/CPP, Oxygenation, Neurological function, ICP, Temperature, Output, Respiratory

Intracranial Pressure (ICP) Monitoring:
- Normal values: 5-15 mmHg supine, <20 mmHg critical threshold
- Waveform analysis: P1 > P2 > P3 indicates normal compliance
- Pathological patterns: P2 > P1 suggests decreased compliance
- CPP calculation: MAP - ICP with target >70 mmHg
- Monitoring duration: Continuous for elevated ICP risk procedures
Processed EEG Monitoring:
- Bispectral Index (BIS): Target 40-60 for adequate anesthesia
- Burst suppression: >80% indicates excessive depth
- Seizure detection: High-frequency activity with amplitude changes
- Ischemia recognition: Slow wave activity and amplitude reduction

Advanced Neuromonitoring Techniques:

Modality	Parameter	Normal Range	Abnormal Threshold	Clinical Significance
SSEP	Latency	<10% increase	>10% increase	Spinal cord function
MEP	Amplitude	>50% baseline	<50% baseline	Motor pathway integrity
BAER	Wave V	<0.5ms delay	>0.5ms delay	Brainstem function
Near-IR	rSO2	>60%	<50%	Cerebral oxygenation

Somatosensory (SSEP): Dorsal column and sensory pathway assessment
- Latency increase >10% or amplitude decrease >50% = significant change
- Anesthetic effects: Volatile agents cause dose-dependent suppression
Motor Evoked Potentials (MEP): Corticospinal tract monitoring
- Amplitude reduction >50% indicates motor pathway compromise
- Anesthetic sensitivity: Neuromuscular blockade must be minimal
Brainstem Auditory (BAER): Posterior fossa procedure essential
- Wave V latency >0.5ms suggests brainstem dysfunction

⭐ Clinical Pearl: TIVA with propofol + remifentanil provides stable evoked potentials while volatile agents >0.5 MAC can suppress MEPs by 80-90%

Cerebral Oxygenation Monitoring:

Near-Infrared Spectroscopy (NIRS):
- Regional oxygen saturation (rSO2): Normal 60-80%
- Critical threshold: <50% or >20% decrease from baseline
- Bilateral monitoring: Asymmetry >10% suggests unilateral pathology
- Trending capability: Real-time ischemia detection during vascular procedures

Near-infrared spectroscopy monitoring showing cerebral oxygen saturation

💡 Master This: Multimodal monitoring combining ICP, EEG, evoked potentials, and cerebral oximetry provides 360-degree neurological surveillance - essential for complex neurovascular and spine procedures with neurological risk.

These monitoring principles integrate seamlessly with emergence strategies, where rapid awakening and immediate neurological assessment validate the success of neuroanesthetic management.

📊 Monitoring Mastery: The Neurological Surveillance Network

Neuromonitoring Techniques

Anesthesia for Neurovascular Procedures

🚀 Emergence Excellence: The Awakening Architecture

Emergence Timeline and Targets:

📌 Remember: AWAKE for emergence priorities - Airway protection, Wake-up timing, Assessment readiness, Keep hemodynamics stable, Emergence quality

Rapid Emergence Protocol (5-15 minutes):
- Anesthetic cessation: Propofol off at dural closure
- Reversal agents: Sugammadex 2-4 mg/kg for rocuronium reversal
- Target timeline: Eye opening <10 minutes, extubation <15 minutes
- Neurological assessment: GCS evaluation within 5 minutes of awakening
Hemodynamic Management During Emergence:
- Hypertension control: SBP target <160 mmHg to prevent hemorrhage
- Antihypertensive options: Labetalol 10-20 mg IV or nicardipine 0.5-2 mg IV
- Avoid hypotension: MAP >65 mmHg maintains cerebral perfusion
- Heart rate control: Target 60-100 bpm with beta-blocker if needed

Emergence Complications and Management:

Complication	Incidence	Recognition	Immediate Management	Prevention Strategy
Hypertension	40-60%	SBP >180	Labetalol/Nicardipine	Smooth emergence
Agitation	15-25%	Confusion/combative	Propofol bolus	Pain control
Delayed awakening	5-10%	No response >20min	Reversal agents	TIVA technique
Respiratory depression	2-5%	RR <10, SpO2 <95%	Naloxone if needed	Opioid titration

Residual anesthetics: Propofol context-sensitive accumulation
Metabolic causes: Hypoglycemia, electrolyte imbalance, hypothermia
Neurological causes: Intracranial hemorrhage, cerebral edema, seizure
Pharmacological: Residual neuromuscular blockade, opioid excess

Neurological assessment tools and Glasgow Coma Scale evaluation

⭐ Clinical Pearl: Smooth emergence prevents intracranial pressure spikes - maintain anesthetic depth until surgical stimulation ceases, then rapid but controlled awakening

Immediate Neurological Assessment Protocol:

Level of consciousness: GCS score with motor, verbal, eye opening
Motor function: Bilateral strength testing and coordination assessment
Cranial nerves: Pupillary response, facial symmetry, speech clarity
Cognitive function: Orientation, memory, following commands
Vital signs: Hemodynamic stability and respiratory adequacy

Quality Emergence Indicators:

Timeline: Awakening <10 minutes, extubation <15 minutes
Hemodynamics: MAP 65-100 mmHg, HR 60-100 bpm
Neurological: Baseline function or expected deficits only
Respiratory: Adequate ventilation without support
Comfort: Pain score <4/10, minimal agitation

💡 Master This: Emergence quality directly correlates with anesthetic technique - TIVA with short-acting agents, multimodal analgesia, and hemodynamic optimization throughout the procedure ensure rapid, smooth, and neurologically intact awakening.

This emergence mastery completes the neuroanesthetic journey from preoperative optimization through intraoperative precision to successful awakening - transforming complex neurosurgical procedures into predictable, safe, and successful patient outcomes through evidence-based neuroanesthetic excellence.

🚀 Emergence Excellence: The Awakening Architecture

Postoperative Care in Neurosurgical Patients

Neuromuscular Disorders

Neuroanesthesia Indian Medical PG Practice Questions and MCQs

Practice Indian Medical PG questions for Neuroanesthesia. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.

Neuroanesthesia Indian Medical PG Question 1: In which clinical scenario would you find a patient requiring the vital signs assessment technique shown in the image?

A. Pulse absent, breath present
B. Pulse and breath both not present
C. Pulse and breath present
D. Pulse present, breath absent (Correct Answer)

Neuroanesthesia Explanation: ***Pulse present, breath absent*** - The image depicts a **mouth-to-mouth resuscitation** technique, specifically rescue breaths being administered by one person to another. - This technique is applied when a person has a **detectable pulse** but is **not breathing** or is only gasping, indicating respiratory arrest while the heart is still circulating blood. *Pulse absent, breath present* - This scenario would represent **cardiac arrest** where the heart has stopped, but the person is still attempting to breathe. This is a rare, transient state. - In such a case, the primary intervention would be **chest compressions**, not just rescue breathing, as circulation is the immediate priority. *Pulse and breath both not present* - This describes **cardiopulmonary arrest (CPA)**, where both the heart and lungs have ceased functioning. - The appropriate intervention is **cardiopulmonary resuscitation (CPR)**, which involves a combination of **chest compressions and rescue breaths (30:2 ratio)**, not just rescue breaths alone. *Pulse and breath present* - If both vital signs are present, the person is **conscious and breathing adequately**, or unconscious but breathing normally. - No advanced respiratory intervention like mouth-to-mouth resuscitation is needed; the priority would be maintaining their airway and monitoring their condition.

Neuroanesthesia Indian Medical PG Question 2: Increase in ICP is due to:

A. Procaine
B. Ketamine (Correct Answer)
C. Prilocaine
D. Bupivacaine

Neuroanesthesia Explanation: ***Ketamine*** - **Ketamine** is known to increase **cerebral blood flow** and metabolic rate, which can lead to an increase in **intracranial pressure (ICP)**. - This effect makes ketamine generally contraindicated in patients with pre-existing elevated ICP or neurotrauma. *Prilocaine* - **Prilocaine** is a **local anesthetic** that does not directly cause increases in ICP. - Its metabolism can produce **o-toluidine**, which can cause **methemoglobinemia**, a side effect unrelated to ICP. *Procaine* - **Procaine** is an **ester-type local anesthetic** that primarily functions by blocking nerve impulses. - It does not have a direct mechanism that would lead to increased **intracranial pressure**. *Bupivacaine* - **Bupivacaine** is a **long-acting local anesthetic** commonly used for regional anesthesia. - While it can cause **cardiovascular depression** and **CNS toxicity** in high doses, it does not typically increase **intracranial pressure**.

Neuroanesthesia Indian Medical PG Question 3: Cerebral blood flow is regulated by all, EXCEPT:

A. Intracranial pressure
B. Cerebral metabolic rate
C. Potassium ions (Correct Answer)
D. Arterial PCO2

Neuroanesthesia Explanation: ***Potassium ions*** - While potassium ions play a crucial role in neuronal excitability and membrane potential, they are **not a primary direct regulator** of cerebral blood flow (CBF) in the same way as other factors listed. - Changes in extracellular potassium can affect vascular smooth muscle, but their direct impact on CBF auto-regulation is less pronounced compared to metabolic or pressure-related factors. *Intracranial pressure* - **Increased intracranial pressure (ICP)** can significantly decrease cerebral blood flow due to the **Monro-Kellie doctrine**, which states that an increase in ICP reduces the cerebral perfusion pressure (CPP). - A sustained and significant elevation in ICP can lead to **cerebral ischemia** as it opposes the arterial pressure driving blood into the brain. *Arterial PCO2* - **Arterial PCO2** is a potent regulator of cerebral blood flow, with **hypercapnia (high PCO2)** causing **vasodilation** and increased CBF. - Conversely, **hypocapnia (low PCO2)** leads to **vasoconstriction** and decreased CBF, which is a key mechanism in the management of cerebral edema. *Cerebral metabolic rate* - **Cerebral metabolic rate (CMR)** is directly coupled to cerebral blood flow, meaning that regions of the brain with higher metabolic activity receive increased blood flow. - This **neurovascular coupling** ensures adequate supply of oxygen and nutrients to meet the brain's metabolic demands.

Neuroanesthesia Indian Medical PG Question 4: Air embolism in neural surgery maximum in which position:

A. Left lateral
B. Sitting (Correct Answer)
C. Supine
D. Trendelenburg

Neuroanesthesia Explanation: ***Sitting*** - In the **sitting position** for neural surgery, the surgical field, particularly the head, is often elevated above the heart. This creates a **negative pressure gradient** in the venous system, increasing the risk of air entrainment if a vein is opened and air is allowed to enter. - The **higher elevation of the operative site** relative to the right atrium significantly increases the likelihood of air being sucked into open veins. *Left lateral* - While air embolism can occur in any position, the **left lateral position** does not inherently create the same significant negative pressure gradient as the sitting position in the surgical field relative to the heart. - The patient's body is positioned on its side, which can help in certain surgical approaches but typically does not elevate the head as dramatically as the sitting position. *Supine* - In the **supine position**, the patient is lying on their back, and the operative field (head or spine) is generally at or below the level of the heart, reducing the pressure gradient that favors air entrainment. - This position typically offers a **lower risk of air embolism** compared to the sitting position due to less negative pressure in exposed veins. *Trendelenburg* - The **Trendelenburg position** involves placing the patient head-down and feet-up, which increases venous pressure in the upper body and head. - This position actively works against the negative pressure gradient, thereby **reducing the risk of air entrainment** into open veins through increased venous pressure.

Neuroanesthesia Indian Medical PG Question 5: Which inhalational agent increases intracranial pressure most significantly?

A. Halothane (Correct Answer)
B. Sevoflurane
C. Isoflurane
D. Desflurane

Neuroanesthesia Explanation: ***Halothane*** - **Halothane** causes a greater increase in **cerebral blood flow** and thus **intracranial pressure (ICP)** compared to newer volatile anesthetics due to its more potent cerebral vasodilation. - Its use has largely declined due to concerns about its effects on ICP and potential for **hepatotoxicity**. *Sevoflurane* - While sevoflurane can cause **cerebral vasodilation** and increase ICP, its effect is generally less pronounced than halothane, especially when normocapnia is maintained. - It is often favored in neuroanesthesia due to its rapid onset and offset, allowing for quicker adjustments in anesthetic depth. *Isoflurane* - Isoflurane causes less cerebral vasodilation and a smaller increase in ICP compared to halothane, particularly at lower concentrations. - It maintains **cerebral vascular autoregulation** better than halothane, helping to preserve a more stable ICP. *Desflurane* - Desflurane also causes cerebral vasodilation and can increase ICP, but its effect is typically less significant than halothane. - Rapid increases in desflurane concentration can lead to sympathetic stimulation and transient increases in blood pressure, which can indirectly affect ICP.

Neuroanesthesia Indian Medical PG Question 6: The position of the patient as shown below is favored for which of the following conditions?

A. CHF
B. Air embolism
C. Neurosurgery
D. Raised ICP (Correct Answer)

Neuroanesthesia Explanation: ***Raised ICT*** - The image depicts the patient in a **reverse Trendelenburg position** (head elevated). This position is often used to reduce **intracranial pressure (ICP)** by promoting venous drainage from the brain. - Elevating the head above the trunk aids in gravity-assisted drainage of cerebral venous blood and cerebrospinal fluid, thereby lowering ICP and preventing complications like brain herniation. *CHF* - Patients with **congestive heart failure (CHF)** often prefer a **Fowler's position** (sitting upright) to ease breathing and reduce pulmonary congestion, not the reverse Trendelenburg as shown. - Lying flat or with feet elevated in CHF can worsen dyspnea and increase cardiac workload due to increased venous return. *Air embolism* - For suspected **air embolism**, the patient is typically placed in the **Trendelenburg position** (head down, feet up) with a left lateral tilt to trap air in the right ventricle and prevent it from entering the pulmonary circulation. - This position helps prevent air from crossing into the left side of the heart thereby reducing the risk of systemic arterial air embolization. *Neurosurgery* - While neurosurgery often involves specific patient positioning, the depicted position isn't uniquely favored for neurosurgery in general. Positioning depends on the surgical site. - The **reverse Trendelenburg** is specifically used when reducing ICP is a primary goal during or after neurosurgical procedures, but not all neurosurgeries.

Neuroanesthesia Indian Medical PG Question 7: Modern monitors to measure ETCO2 make use of

A. Laser technology
B. Scatter technology
C. Infrared absorption spectroscopy (Correct Answer)
D. Ultra violet rays

Neuroanesthesia Explanation: ***Infrared absorption spectroscopy*** - This technique relies on the principle that carbon dioxide molecules **absorb infrared light** at specific wavelengths. - A sensor measures the **amount of infrared light absorbed** by the exhaled gases, which is directly proportional to the CO2 concentration. *Laser technology* - While lasers are used in some advanced medical diagnostics, they are **not the primary technology** employed for routine ETCO2 monitoring. - Laser-based techniques for gas analysis are often more complex and **less commonly integrated** into portable or standard capnographs. *Scatter technology* - **Light scattering** methods are typically used to measure particle size or concentration in solutions or aerosols, not gas concentrations. - This technology is **not suitable for detecting specific gas molecules** like CO2 in a breath sample. *Ultra violet rays* - Carbon dioxide molecules **do not significantly absorb ultraviolet (UV) light** in a way that allows for reliable quantitative measurement in medical settings. - UV spectroscopy is used for detecting different types of molecules, but **infrared absorption is specific to CO2** for capnography.

Neuroanesthesia Indian Medical PG Question 8: A patient with mitral stenosis is having surgery tomorrow. There is some liver compromise. Which of the following inhalational agents is preferred?

A. Enflurane
B. Xenon
C. Sevoflurane (Correct Answer)
D. Halothane

Neuroanesthesia Explanation: ***Sevoflurane*** - **Sevoflurane** is preferred due to its **minimal hepatic metabolism** and rapid elimination, making it a safer option in patients with **liver compromise**. - It maintains **cardiovascular stability**, which is beneficial in mitral stenosis and avoids the arrhythmogenic potential seen with other agents. *Enflurane* - **Enflurane** is extensively metabolized in the liver, leading to the production of inorganic fluoride ions, which can cause **renal toxicity**. - It can also induce a decrease in **hepatic blood flow**, exacerbating existing liver compromise. *Xenon* - While **Xenon** has excellent cardiovascular stability and minimal metabolism, its **high cost** and **limited availability** make it an impractical choice for routine use. - Its anesthetic potency is relatively low, requiring **higher concentrations** for surgical anesthesia. *Halothane* - **Halothane** is associated with a significant risk of **halothane-induced hepatitis** due to its extensive hepatic metabolism and the production of toxic metabolites. - It can also cause **cardiac depression** and **arrhythmias**, which are undesirable in patients with mitral stenosis.

Neuroanesthesia Indian Medical PG Question 9: Which of the following is the induction anesthesia of choice in the pediatric age group?

A. A. Sevoflurane (Correct Answer)
B. B. Desflurane
C. C. Halothane
D. D. Isoflurane

Neuroanesthesia Explanation: ***A. Sevoflurane*** - **Sevoflurane** is an inhalation anesthetic widely preferred for **pediatric induction** due to its rapid onset and non-pungent odor, which makes it well-tolerated by children. - Its low blood-gas partition coefficient allows for swift changes in anesthetic depth and rapid emergence. *B. Desflurane* - **Desflurane** has a **pungent odor** and is known to cause airway irritation, making it unsuitable for inhalational induction in children. - Its rapid onset and offset are beneficial, but its irritant properties limit its use for induction, especially in younger patients. *C. Halothane* - **Halothane** was previously used for pediatric induction but has largely been replaced due to its association with **hepatotoxicity** and cardiac arrhythmias. - It also has a slower onset and offset compared to newer agents like sevoflurane. *D. Isoflurane* - **Isoflurane** has a **pungent odor** and can cause airway irritation, making it less suitable for inhalational induction in children compared to sevoflurane. - While effective for maintenance, its irritant properties make for a less smooth and potentially distressing induction experience for pediatric patients.

Neuroanesthesia Indian Medical PG Question 10: Which of the following anaesthetic agent causes bone marrow suppression?

A. Isoflurane
B. Halothane
C. Ketamine
D. Nitrous Oxide (Correct Answer)

Neuroanesthesia Explanation: ***Nitrous Oxide*** - **Nitrous oxide** can cause **bone marrow suppression** due to its ability to irreversibly oxidize the **cobalamin cofactor** of **methionine synthase**. - This inactivation leads to reduced DNA synthesis and impacts rapidly dividing cells like those in the bone marrow, potentially causing **megaloblastic anemia** with prolonged or repeated exposure. *Isoflurane* - **Isoflurane** is a volatile anesthetic known for its minimal effects on bone marrow function. - It primarily acts on the central nervous system to induce anesthesia and muscle relaxation with limited systemic toxicities. *Halothane* - **Halothane** is associated with **hepatotoxicity** (halothane hepatitis) in some susceptible individuals, but not bone marrow suppression. - Its use has largely been replaced by newer, safer volatile anesthetics due to this risk. *Ketamine* - **Ketamine** is a dissociative anesthetic that primarily affects the central nervous system, causing analgesia and amnesia. - It does not significantly impact bone marrow function or hematopoiesis.

More Neuroanesthesia Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.

Neuroanesthesia

On this page

🧠 Neuroanesthesia: The Brain's Guardian Protocol

🧠 Neuroanesthesia: The Brain's Guardian Protocol

Awake Craniotomy

Cerebral Physiology and Pathophysiology

⚡ Cerebral Hemodynamics: The Brain's Circulation Command Center

⚡ Cerebral Hemodynamics: The Brain's Circulation Command Center

Anesthetics and Cerebral Blood Flow

Intracranial Pressure Management

🎯 Anesthetic Agents: The Neurochemical Arsenal

🎯 Anesthetic Agents: The Neurochemical Arsenal

Anesthesia for Supratentorial Craniotomy

Anesthesia for Traumatic Brain Injury

🔄 Positioning Protocols: The Spatial Strategy Matrix

🔄 Positioning Protocols: The Spatial Strategy Matrix

Anesthesia for Infratentorial Craniotomy

Anesthesia for Spine Surgery

📊 Monitoring Mastery: The Neurological Surveillance Network

📊 Monitoring Mastery: The Neurological Surveillance Network

Neuromonitoring Techniques

Anesthesia for Neurovascular Procedures

🚀 Emergence Excellence: The Awakening Architecture

🚀 Emergence Excellence: The Awakening Architecture

Postoperative Care in Neurosurgical Patients

Neuromuscular Disorders

Practice Questions: Neuroanesthesia

Flashcards: Neuroanesthesia

Enjoying this lesson?